IMO, looking forward to being surprised by management with additional paxalisib regional GBM deals this year together with a FDA approval by the end of next year.
EVT801 trial data presentations should also increase the future share value.
Regards.
- Forums
- ASX - By Stock
- KZA
- Ann: GBM Agile opens to paxalisib in Europe
Ann: GBM Agile opens to paxalisib in Europe, page-13
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity